
==== Front
Vet Res
Vet Res
Veterinary Research
0928-4249
1297-9716
BioMed Central London

39252070
1364
10.1186/s13567-024-01364-0
Research Article
Prevalence and risk factors associated with nasal carriage of methicillin-resistant staphylococci in horses and their caregivers
http://orcid.org/0000-0002-9094-6734
Bullone Michela michela.bullone@unito.it

1
Bellato Alessandro 1
Robino Patrizia 1
Nebbia Patrizia 1
Morello Sara 2
Marchis Daniela 2
Tarducci Alberto 1
Ru Giuseppe 3
1 https://ror.org/048tbm396 grid.7605.4 0000 0001 2336 6580 Department of Veterinary Sciences, University of Torino, Largo Paolo Braccini 2, 10095 Grugliasco, Italy
2 grid.425427.2 0000 0004 1759 3180 Feed Hygiene Laboratory, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, via Bologna 148, 10154 Torino, Italy
3 grid.425427.2 0000 0004 1759 3180 Biostatistics, Epidemiology and Risk Analysis Unit, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, via Bologna 220, 10154 Torino, Italy
Handling editor: Quirine ten Bosch.

9 9 2024
9 9 2024
2024
55 10810 11 2023
17 7 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Antimicrobial resistance is a global threat, and pet-associated strains may pose a risk to human health. Equine veterinarians are at high risk of carrying methicillin-resistant staphylococci (MRS), but specific risk factors remain elusive, and few data are available for other personnel involved in the horse industry. The prevalence, characteristics, and risk factors for nasal carriage of MRS in horses and their caregivers were studied in northwestern Italy. Nasal swabs from 110 asymptomatic horses housed at 21 barns and 34 human caregivers were collected. Data on barns, horses, and personnel were acquired through questionnaires. The samples were incubated in selective media, and the bacterial isolates were identified by mass spectrometry. Risk factors were investigated by Poisson regression. MRS were isolated from 33 horses (30%), 11 humans (32.4%) and 3 environmental samples (14.2%). Most isolates were multidrug resistant (MDRS). The prevalence of MRS and MDRS was greater in racehorses and their personnel than in pleasurable and jumping/dressing horses. MRS carriage in caregivers was associated with an increased prevalence of MRS carriage in horses. The frequency of antimicrobial treatments administered in the barn during the last 12 months was a risk factor for MRS carriage in horses [prevalence ratio (PR) 3.97, 95% CI 1.11, 14.13] and caregivers (PR 2.00, 95% CI 1.05, 3.82), whereas a good ventilation index of the horse tabling environment was a protective factor (PR 0.43, 95% CI 0.20, 0.92). Our data reveal relevant interactions occurring between bacterial communities of horses and humans that share the same environment, suggesting that One Health surveillance programs should be implemented.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13567-024-01364-0.

Keywords

Horse
nasal carriage
methicillin-resistant staphylococci (MRS)
risk factors
antimicrobial resistance
AMR genes
http://dx.doi.org/10.13039/100007364 Fondazione CRT Erogazioni Ordinarie (RF #2018.0587). Tarducci Alberto issue-copyright-statement© L’Institut National de Recherche en Agriculture, Alimentation et Environnement (INRAE) 2024
==== Body
pmcIntroduction

Antimicrobial resistance represents a global threat to human and animal health. Livestock and pet-associated strains of antimicrobial-resistant staphylococci have been identified as possible, although uncommon, sources of infection in humans. Animal-associated Staphylococcus strains, both pathogens and commensals, can also act as reservoirs of antimicrobial resistance and virulence genes [1, 2]. From this perspective, veterinary epidemiological surveillance is a recognized fundamental process for the achievement of the One Health approach.

Among the resistance traits that staphylococci can acquire, methicillin resistance is considered the most important trait from a clinical point of view, as β-lactam antibiotics are the most prescribed class of antimicrobials in veterinary and human medicine [3, 4]. Methicillin resistance is mediated by the mecA or mecC genes, which encode alternative penicillin-binding proteins with a low affinity for β-lactam antibiotics. Methicillin-resistant Staphylococcus aureus (MRSA) is the bacterial agent of the Staphylococcus genus with the highest pathogenic potential, and it is recognized as a zoonosis [3, 5]. With increasing awareness of the global threat posed by antimicrobial resistance, surveillance for MRSA colonization in asymptomatic hosts has been implemented in many countries [6–9]. This made it possible to recognize equine veterinarians as being at increased risk of colonization or infection by MRSA compared with other veterinarians and non-veterinary people [10]. Less information is available concerning other methicillin-resistant staphylococci (MRS). Coagulase-negative staphylococci (CoNS) are mucosal and skin commensal bacteria characterized by a reduced capacity to cause acute, life-threatening infections compared with coagulase-positive staphylococci. CoNS and methicillin-resistant CoNS (MRCoNS) are, however, increasingly important pathogens that cause infections in immunocompromised human patients and after transplantation [11, 12]. The role of CoNS in equine infections is also increasingly recognized [13].

There is scientific evidence supporting the horizontal transmission of MRS strains between humans and horses (reviewed in [13]). A limited number of studies investigating the factors potentially associated with an increased prevalence of MRS colonization in asymptomatic horses and their caregivers are available [14–20]. The horses’ intended use or activity, namely, racing vs. other equestrian activities, as well as an increased number of horses stabled at the same facility, have been indicated as possible risk factors for MRCoNS and MRSA isolation in equine populations [16, 21–23]. Researchers have not explored whether horse caregivers are also subject to different risks on the basis of their horses’ intended use or activity.

The present study was designed to fulfil the following aims: (1) estimate the prevalence of nasal MRS colonization (in the manuscript from now on, described as MRS colonization) in asymptomatic horses stabled in our geographical area and their caregivers; (2) characterize the MRS strains isolated; and (3) assess the role of potential risk factors for MRS colonization in both species. On the basis of the literature mentioned above [16, 21–23], we hypothesized that racehorses and their caregivers are at increased risk of MRS colonization compared with pleasure horses and their caregivers.

Materials and methods

The methodologies employed are fully detailed in Additional file 1.

Study design

The study had a prospective cross-sectional design. Horse, personnel, and environmental swab samples were obtained from external barns (racing, riding or pleasure riding barns) and an internal teaching barn from our Department for MRS isolation and subsequent antimicrobial resistance profiling. The feed samples were obtained from external barns for antimicrobial residue testing. Specific questionnaires were employed to collect relevant information at the horse, personnel, and barn levels for risk factor analyses. The samples were collected from the end of July to the end of November 2019. Samples and data were collected by the same operators throughout the study period. Written informed consent was obtained from the owners of the studied horses and from the recruited people. The study was approved by the Animal Ethical and Welfare Committee of the Department of Veterinary Medicine (Prot. N. 936, 16/04/2019), University of Turin, and by the Ethical Committee of the Azienda Ospedaliera Universitaria San Luigi Gonzaga (Prot. 63/2019) for the equine and human parts, respectively. The procedures described for horses were performed in accordance with Directive 2010/63/EU on the protection of animals used for scientific purposes. The study conformed to the Declaration of Helsinki.

External barns

Barns of Standardbred racehorses, show jumping or dressage horses (collectively described as show riding horses), and pleasure riding horses located in the Turin area were selected through convenience sampling and included a 1:1:1 ratio until reaching a total of 21 barns. Only barns with ≥ 7 horses were selected to increase the study power, on the basis of previous data indicating that the number of horses stabled at the barn is a risk factor for MRS colonization [16].

Internal barn

The internal teaching barn of the Department of Veterinary Medicine of the University of Turin was included as a putative positive control barn, as a high prevalence of MRS was expected both in horses and humans working in this environment. It was located in close proximity to the equine hospital barn. Five asymptomatic horses permanently stabled at the teaching barn and an equine veterinarian working there were sampled, as they were expected to be at higher risk of MRS colonization on the basis of the available literature [10, 24, 25].

Horses

For each external barn, four to seven horses were sampled, randomly chosen among those considered eligible. The inclusion criteria were (i) being clinically asymptomatic, as reported by the owner and confirmed by interviewing the attending veterinarian, and (ii) not having received any antimicrobial treatment in the previous two months. This was considered the shortest time required for an altered bacterial flora to recover from antimicrobial treatment on the basis of available evidence [15, 26]. Horses reluctant to have their nose manipulated were excluded a priori.

Personnel

Personnel working at the barns studied were included on a voluntary basis, with a maximum of two persons per barn.

Questionnaires and feed data collection

Data were collected by means of specific questionnaires (Additional file 2) at three levels: barn (same data for all horses sampled in that barn), horse (animal individual data), and personnel (human individual data). Further details on the gathered information are available online. Whenever possible, barn-level questions were asked to horse owners or to barn personnel not included in the study to validate the responses. Similarly, data concerning pharmacological treatments for horses were validated by interviewing the attending veterinarian. In the case of contrasting information, data were excluded from the analysis. Information concerning the feeds sampled was also obtained at the barn (name of the product, stocking modalities, and picture of commercial label when available) and by means of computer-based research (company producing feed for other animal species or medicated feed).

Nasal sampling

Fifteen cm long rayan-tipped swabs (Transystem™ 110 C, Copan Diagnostics Inc.) moistened with sterile saline solution were employed. Swabs were inserted approximately 15 cm into both horse nares and 2 cm into one nostril, which was randomly chosen, of each person studied. The swabs were gently pushed and rotated onto the equine or human nasal mucosa for a minimum of 5 s, trying to sample the whole mucosal area down to the external naris openings. In horses, care was taken to introduce the swab deep in the ventral meatus and to sample the mucosa of the nasal vestibulum while moving rostrally, as this site was associated with increased sensitivity for MRSA carrier identification in horses [27]. The same swab was used to sample both nostrils of the same horse. The swabs were discarded, and the procedure was repeated if contamination occurred during sampling.

Environmental sampling

One environmental sample per barn was obtained using a 15 cm long rayan-tipped swab over a 10 cm2 area, typically from a lateral wall of the shower area. This sampling site was chosen because the shower area is used by all horses from the stable.

MRS isolation and assessment

The swabs were kept at 4 °C in Amies agar gel transport medium and processed within 24 h for selective isolation of MRS spp. following standard protocols [28, 29]. Isolated colonies were initially identified by morphology, Gram staining, culture media colour changes, and catalase and coagulase tests. Bacterial species identification was performed via whole-cell MALDI-TOF mass spectrometry (Microflex®, Bruker Daltonics Inc.). DNA was extracted from the isolates, and PCR was performed for the 16 S, mecA, mecC and nuc genes as previously described [30].

Antimicrobial susceptibilities of the isolated colonies were determined using the Kirby–Bauer disk-diffusion method for penicillin, ceftiofur Na, gentamicin, enrofloxacin, tetracycline, erythromycin, and trimethoprim-sulfamethoxazole. EUCAST breakpoints were used to define resistance, except for ceftiofur and enrofloxacin, for which they were unavailable. CLSI breakpoints have been used instead. Staphylococcus spp. resistant to three or more antimicrobial molecules among those tested were defined as multidrug-resistant (MDR) staphylococci (MDRS).

Feed sampling and assessment

Feed samples of approximately 500 g each were collected from feed storage bins or tanks, placed in triple plastic bags, and stored at −20 °C until subsequent analysis. Only the feeds consumed by the horses sampled were selected in a variable number on the basis of their diets, with no restrictions. Hay was not sampled. Antimicrobial residue analysis of the feed was performed via multiresidue UPLC‒MS/MS, which allowed the detection of 43 target antibiotics (Additional file 3) with a limit of detection (LOD) of 50 µg/kg and a limit of quantification (LOQ) of 250 µg/kg.

Statistical analysis

Data from the internal barn are described but are consistently excluded from the analyses. In the evolving panorama of AMR in veterinary medicine, the inclusion of this barn served to confirm observations reported in previous data and the appropriateness of any comparison with previous literature. Data analysis was performed via STATA v15.1 (StataCorp LLC, College Station, Texas, USA). Continuous data are expressed as the mean ± standard deviation (SD) and were compared with the Kruskal‒Wallis test, as all datasets assessed were not normally distributed according to the Shapiro‒Wilk normality test. The chi-square test was used to compare data expressed as proportions. The prevalence of MDRS colonization was used to obtain prevalence ratios (PRs) and relative 95% CIs via a robust variance estimate. The frequencies of travel and antimicrobial treatments were calculated as rates and expressed as events/horse-months. Using pleasure riding horses as a reference category, the travel rate ratio and antimicrobial treatment rate ratio were obtained using Poisson regression with robust cluster variance estimates.

Risk factors for nasal colonization by ≥ 1 MRS (dichotomous dependent variable) were initially assessed with bivariate unadjusted Poisson regression with the alpha set at 0.1. Variables perfectly associated with the outcome at this step were excluded from further analyses, as the observed effect was attributed to the low number of observations available. As our questionnaire included multiple variables concerning air quality (number of windows or openings in the box, paddock exposure, and number of hours at paddock per day), considering the importance attributed to the airborne transmission of respiratory pathogens, an ordinary variable named the ventilation index was created and included in the risk analysis. The ventilation index was attributed to a value of 0, or poor, for horses stabled in a box with only one opening for ≥ 22 h/day (weekly mean; which corresponds to ≤ 2 h/day at pasture); a value of 1, or good, for horses stabled in a box with only one opening for ≥ 12 and ˂22 h per day (weekly mean; corresponding to > 2 and up to 12 h/day at pasture), or stabled in a box with > 1 opening, independent of turnout time; and a value of 2, or optimal, for horses kept at pasture for > 12 h per day (weekly mean), independent of the number of box openings. A minimum size of 80 × 80 cm2 was used to define box openings. Boxes with one or more lateral walls not reaching the roof were considered to have ˃1 opening. Variables found to be associated with the outcome were included in mixed-effect Poisson multivariate analyses where the barn was treated as a within-subject (random) factor. Multicollinearity was expected and assessed by uncentered variance inflation factors (VIFs). If ≥ 2.5, the covariates were singularly removed from the model to prevent multicollinearity-induced bias [31], and the model was repeated until the VIFs of all the covariates were < 2.5. Variance estimates were always adjusted for clusters (barn). The goodness of fit of the Poisson regression models used was tested via Pearson and deviance statistics.

Results

Twenty-one external barns were studied: six Standardbred racing barns, seven show riding, and eight pleasure riding barns. The details are reported in Table 1.

Table 1 Details of the barns and horses studied

	Internal barn	Racehorse barns	Show riding barns	Pleasure riding barns	All external barns	
Barns [n]	1	6	7	8	21	
Barns where tacks are shared [n]	1	4	2	3	9	
Total horses [n]	5	104	225	286	615	
Horses per barn [n]	5	17 ± 9	32 ± 15	32 ± 14	27 ± 14	
Total horses sampled [n]	5	33	38	39	110	
Age [years]	16.0 ± 7.4	5.5 ± 3.6	13.0 ± 4.4*	13.6 ± 6.8*	11.1 ± 6.3	
Sex [M: F]	2:3	17:14	25:13	23:16	65:43	
Weight [kg]	476 ± 33	440 ± 52	516 ± 93*	478 ± 170	481 ± 123	
Travelling rate ratio [IRR (95%CI)]	–	3.06 (1.13, 8.27)	1.48 (0.49, 4.51)	1.00	–	
Hospitalizations last year [n]	0	1	4	0	5	
Horses intended for food consumption [n]	1	3	0	7	10	
Horse-specific antimicrobial treatment rate ratio [IRR (95% CI)]	–	3.16 (0.84, 11.84)	2.31 (0.63, 8.54)	1.00	–	
Barn-estimated antimicrobial treatment rate ratio [IRR (95% CI)]	1.50	10.00 (4.16, 23.97)	2.00 (0.81, 4.97)	1.00	–	
The data are expressed as absolute counts or means ± SD. Data from the internal barn were systemically excluded from the statistical analyses. “All external barns” includes data from the 21 racehorses and shows riding barns. Barn estimates of antimicrobial treatments administered are based on personnel interviews and cover all horses stabled at the barn during the 12 months preceding the interview. Horse-specific values are based on personnel interviews and cover antimicrobial treatments administered in the last 12 months only to the horses included in the study. IRR were compared with Poisson regression and robust variance estimates.

*Significantly different from racehorse barns (p < 0.05, Kruskal‒Wallis test).

Horses

The horses from the external barns (n = 110) included 32 Standardbred racehorses, 13 ponies, 5 draft horses, 51 show jumping horses (French, Italian, German, or mixed breed), 5 Quarter horse-related breeds, and 4 Lipizzaner horses. Information on pharmacological treatment was always in agreement when verified; thus, there was no exclusion from the database due to data disagreement. Racehorses (n = 33) were younger compared to show (n = 38) and pleasure riding (n = 39) horses and had shorter permanence times (length of stay) at the barn compared to pleasure horses (Table 1). The rates of travel and barn-estimated antimicrobial treatment administration were higher in racehorses than in pleasure horses. After bacterial species identification, 33 isolates (from 33 horses out of 110) were recognized as MRS, corresponding to an overall 30% prevalence of MRS colonization in asymptomatic horses from our region (95% CI 21.6, 39.5%). In the same population, the prevalence of MDRS colonization was 18.2% (95% CI 11.4, 27.7%). Details of the nonstaphylococcal methicillin-resistant isolates are described in Additional file 1. The prevalence of MRS and MDRS colonization was higher in racehorses than in pleasure horses (Table 2). The horse-associated MRS were all MRCoNS, mainly S. sciuri (n = 17) and S. fleurettii (n = 9), with lower prevalences of S. equorum (n = 3), S. lentus (n = 2), S. cohnii (n = 1) and S. saprophyticus (n = 1). All the isolates expressed the 16 S gene, 26 expressed the mecA gene, and two expressed both the mecA and the mecC genes. None of them expressed the nuc gene. Among the 33 MRS, nine were resistant to one class of antimicrobial, five were resistant to two classes of antimicrobial, and 20 were MDRS (60.6%, 95% CI 42.1, 77.1%). In the internal barn, eight MRS were isolated from the five horses sampled, corresponding to a 100% prevalence. They were identified as S. aureus (n = 1), S. equorum (n = 1), S. fleurettii (n = 2), S. lentus (n = 2) and S. sciuri (n = 2). One horse harboured four isolates. Seven isolates expressed the mecA gene; one expressed the nuc gene (S. aureus), whereas none expressed the mecC gene. Among the five isolates from the teaching herd, one showed in vitro resistance to one class of antimicrobial, two to two classes of antimicrobial, and five to three or more antimicrobial agents (MDRS).

Table 2 Nasal carriage of MRS and MDRS in horses by their intended use

	Internal barn	Racehorses	Show horses	Pleasure horses	All external barns	
Horses [n]	5	33	38	39	110	
Horses with ≥ 1 MRS [n]	5	14	10	9	33	
Prevalence of MRS carriage (95% CI)	1	0.42

(0.28, 0.58)

	0.26

(0.13, 0.46)

	0.23

(0.10, 0.45)

	0.30

(0.21, 0.41)

	
Prevalence ratio for MRS carriage [PR (95% CI)]	–	1.84 (0.83, 4.07)	1.14 (0.44, 2.92)	1	–	
Horses with ≥ 1 MDRS [n]	2	10	8	2	20	
Prevalence of MDRS carriage (95% CI)	0.40	0.30

(0.16, 0.50)

	0.21

(0.08, 0.44)

	0.05

(0.01, 0.17)

	0.18

(0.10, 0.30)

	
Prevalence ratio for MDRS carriage [PR (95% CI)]	–	5.91 (1.55, 22.52)	4.10 (0.96, 17.58)	1	–	
“All external barns” includes data from the 21 racehorses and shows riding barns.

Personnel

The personnel tested included 34 people taking care of the horses sampled in the external barns studied and one veterinarian working at the Equine University Teaching Hospital and internal barn. Details are provided in Table 3. The prevalence of MRS colonization was higher in personnel working with racehorses compared to show riding and pleasure horses, and a similar pattern was observed for MDRS (Table 4). MRS were identified in 11 human samples, corresponding to a 32% prevalence of MRS colonization (95% CI 17.4, 50.5%). S. epidermidis (n = 4), S. sciuri (n = 3), S. cohnii (n = 2), S. hominis (n = 1) and S. haemolyticus (n = 1) were identified, all MRCoNS. Two of these isolates were resistant to molecules from a single antimicrobial class, three were resistant to molecules from two antimicrobial classes, and six were MDR strains. Nine isolates expressed the mecA gene, whereas none of them expressed the nuc or mecC gene. The isolate obtained from the veterinarian was an MDR S. aureus strain expressing mecA and nuc genes that was resistant to all the antimicrobial molecules tested.

Table 3 Details of the personnel studied

	Internal barn	Racehorse barns	Show riding barns	Pleasure riding barns	All external barns	
Human subjects [n]	1	11	10	13	34	
Age [years]	45	45 ± 11	41 ± 13	32 ± 14	38 ± 13	
Sex [M: F]	1:0	9:2	3:7	7:6	19:15	
Time from recruitment [years]	18	12 ± 11	5 ± 4	11 ± 9	10 ± 9	
Any disease [n]	0	1	1	2	4	
Antimicrobial treatments in the last 2 months [n]	0	0	2	3	5	
Antimicrobial treatment rate in the last 2 months [treatment/person-months]	0	0	0.10	0.11	0.07	
Time spent at the barn daily [h	4	8 ± 2	12 ± 6	8 ± 4	9 ± 4	
Time spent at the barn manipulating horses [h]	1	5 ± 2	7 ± 4	5 ± 3	6 ± 3	
Hand washing daily frequency [n]	20	7 ± 6	12 ± 9	5 ± 5	7 ± 7	
After excluding data from the internal barn, Kruskal-Wallis comparisons were run without detecting any statistically significant differences. “All external barns” includes data from the 21 racehorses and shows riding barns. The data are expressed as absolute counts or means ± SD.

Table 4 Nasal carriage of MRS and MDRS for the personnel studied by horse intended use

	Internal barn	Racehorse barns	Show riding barns	Pleasure riding barns	All external barns	
Human subjects [n]	1	11	10	13	34	
Human subjects with MRS [n]	1	8	1	2	11	
Prevalence of human nasal MRS carriage (95% CI)	1.00

(1.00–1.00)

	0.73

(0.31, 0.94)

	0.10

(0.01, 0.48)

	0.15

(0.03, 0.48)

	0.32

(0.16–0.55)

	
Prevalence ratio for human nasal MRS carriage [PR (95% CI)]	–	4.72 (1.21, 18.40)	0.65 (0.07, 5.80)	1.00	–	
Human subjects with MDRS [n]	1	5	0	1	6	
Prevalence of human nasal MDRS carriage (95% CI)	1.00

(1.00, 1.00)

	0.45

(0.17, 0.77)

	0.00

(0.00, 0.00)

	0.077

(0.01, 0.41)

	0.18

(0.07–0.38)

	
Prevalence ratio for human nasal MDRS carriage [PR (95% CI)]	–	5.91 (0.81, 43.11)	0.00 (0.00, 0.00)	1.00	–	
“All external barns” includes data from the 21 racehorses and shows riding barns.

Environment

The environmental samples yielded a total of four MRS isolates from three barns (14.3%). They were all MRCoNS identified as S. sciuri (n = 2), S. lentus (n = 1) or S. cohnii (n = 1). The mecA gene was expressed by three (75%) MRS isolates. One MDR S. equorum strain expressing mecA was isolated from an environmental sample from a university barn.

Antimicrobial residues in feeds

Twenty-one complimentary preparations and 13 single cereal feed samples (total n = 34) were collected from the 21 external barns studied (median 1; range 0–5). None of the tested antimicrobial molecules appeared to exceed the LOQ in the feeds studied. Traces of oxytetracycline, amoxicillin, sulfadimetoxin, and tiamulin were found in three of the 21 complementary feed samples, which were obtained from three different barns and provided by two of the 18 different manufacturers tested, both of which produced medicated feeds intended for livestock species.

Risk factor analyses

The bivariate unadjusted analyses revealed barn activity, the habit of using shared tacks, the barn-estimated antimicrobial treatment ratio, being stabled in a box with > 1 window or opening, and the ventilation index as factors significantly associated with MRS colonization in horses (Additional file 1A). There were 25 horses kept exclusively at paddock. For them, information on the number of openings in their box was lacking. We choose to use the variable ventilation index instead of the number of openings in the box for inclusion in the multivariate model so that all 110 horses can be studied together. Additionally, barn activity was removed because it was considered biologically irrelevant. As fomites are a recognized transmission factor for respiratory infections in horses [32, 33], a significant association was expected and observed between shared tacks and the barn-estimated antimicrobial treatment ratio, with the latter being significantly higher in the presence vs. absence of shared tacks (mean ± SD, 0.58 ± 0.64, n = 45 vs. 0.18 ± 0.19, n = 65). Additionally, stratified analysis revealed different effects of the barn-estimated antimicrobial treatment ratio on MRS carriage in the presence and absence of shared tacks (PR 1.12, 95% CI 0.7, 1.75 vs. 4.44, 95% CI 1.22, 16.08). Given the potential implications of both variables as risk factors for MRS colonization, a further interaction factor was inserted into the model. The barn-estimated antimicrobial treatment ratio was recognized as a risk factor for MRS colonization in horses, with a significant interaction with shared tacks, while good and optimal ventilation indexes were protective factors compared with poor ventilation index (Table 5). The use of shared tacks per se was not recognized as a risk factor in our study, possibly due to a lack of power. The overall performance of the fitted model was good, as the Pearson and deviance statistics revealed a nonsignificant lack of fit (p = 0.99 and p = 0.98, respectively). When the ventilation index was modelled as a continuous variable instead of an ordinal variable, the statistical significance of the effect was maintained.

Table 5 Mixed-effects multivariate Poisson analysis with barn included as a random effect and cluster variance (robust) estimates

	PR	95% CI	
Ventilation index			
 Score 0	Ref.	–	
 Score 1	0.43	0.20, 0.92	
 Score 2	0.44	0.20, 0.95	
Shared tacks	2.19	0.96, 4.99	
 Barn-estimated antimicrobial treatment ratio	4.16	1.15, 15.01	
 Interaction Shared tacks*Barn estimated antimicrobial treatment ratio	0.22	0.05, 0.93	
The results are expressed as prevalence ratios (PR) for a horse being a nasal carrier of ≥ 1 MRS. n = 110. Bold indicates variables significantly associated with equine MRS carriage.

Bivariate analyses performed on personnel data revealed gender, barn activity (reference: pleasure riding), number of horses studied at the barn carrying nasal MRS, barn-estimated antimicrobial treatment ratio, and having a colleague (other personnel employed at the barn and participating in the study) carrying nasal MRS as potential risk factors associated with MRS colonization in horse caregivers (Additional file 1B). Again, barn activity was removed from the model. The final model identified the barn-estimated antimicrobial treatment ratio as the only risk factor significantly associated with human MRS colonization (Table 6). The overall performance of the fitted model was good, as determined by the Pearson and deviance statistics (p = 0.98 and p = 0.93, respectively).

Table 6 Mixed-effects multivariate Poisson analysis with barn included as a random effect and robust cluster variance estimates

	PR	95% CI	
Sex [ref: female]	2.17	0.65, 7.21	
Barn-estimated antimicrobial treatment ratio	2.00	1.05, 3.82	
 N horses carrying MRS	1.29	0.87, 1.92	
Colleague carrying intranasal MRS	2.10	0.81, 5.49	
The results are expressed as prevalence ratios (PR) for a human being who is a nasal carrier of ≥ 1 MRS. n = 34. Bold indicates variables significantly associated with human MRS carriage.

There were seven out of 21 external barns where MRS were isolated from nasal swabs of both horses and personnel. Among them, four were barns of racehorses (4/6, 67%), one was a show horse (1/7, 14%), and two were pleasure horses (2/8, 25%). The same bacterial species (S. sciuri) with the same antimicrobial resistance pattern was identified in both horses (n = 2 out of five tested) and personnel (n = 1 out of two tested), suggesting possible direct horizontal transmission. In two other barns, overlapping antimicrobial resistance patterns could be observed in human and equine isolates, but the bacterial species differed (S. epidermidis and S. sciuri in humans vs. S. fleurettii and S. cohnii in horses).

Discussion

In the geographical area studied in northwestern Italy, MRS colonization was detected in one-third of the horses and personnel studied. The overall prevalence of MR-CoNS colonization observed in horses was consistent with the literature [6, 17, 18]. Our inability to detect MRSA was also in line with reported prevalence rates < 2% in horses in our region and, more broadly, in Europe and Canada [21, 23, 24, 34, 35]. Our sampling could not reveal the presence of MRSA colonization in the equine and human populations studied, with the only exception being one equine veterinarian working at our University Hospital. This finding also agrees with previous data indicating that equine veterinarians are at increased risk of nasal carriage of MRSA compared with people not professionally exposed to animals or to asymptomatic persons in the community [7–9]. More than half of the isolates were MDRS, with similar distributions across equine and human species. The results of this study indicate that antimicrobial treatment frequency in horses is the main factor associated with both equine and human nasal carriage of MRS. These findings emphasize the interactions among the bacterial communities of horses and humans in the same environment. Another finding of this study concerns the protective effect of better air quality against MRS carriage in the horses studied, supporting the well-recognized importance of good air exchange in controlling microbial spread in the community.

There is no doubt that the recent administration of antimicrobials can lead to resistance in bacterial populations of living organisms receiving treatment, particularly when they are used inappropriately. Published evidence shows that the administration of antimicrobial treatment during the last 30 days is a risk factor for MRSA nasal carriage in horses [15]. Much less is known concerning the dynamics of AMR acquisition by bacteria as well as the duration of colonization by MRS of the equine nose, although colonization times of up to 5 months have been reported. Despite the increased availability of data on the prevalence of MRSA and MRS in equine populations and equine industry personnel [36–39], studies of risk factors specifically associated with MRS carriage or colonization in horses and their caregivers remain scarce and limited to MRSA [20, 40]. From this perspective, our study was designed to specifically investigate risk factors other than recent antimicrobial treatment for MRS colonization of horses and their caregivers. In particular, variables used to study antimicrobial exposure in horses have been chosen to address the long-term impact of the total burden of antimicrobial treatments performed at the barn rather than in a single animal (barn-estimated antimicrobial treatment vs. horse-specific antimicrobial treatment in the last 12 months, indirect vs. direct effect/exposure). The inclusion criterion was to minimize the effect of recent direct exposure to antimicrobial treatments in the horses tested (e.g., to be free from antimicrobial treatment for at least 2 months before enrolment and sampling). The time interval of two months was chosen on the basis of data on AMR clearance times reported in non-staphylococcal species colonizing the equine gut [26]. The other variables studied as possible risk factors for horses included environmental contamination (from barn walls/fences or feeds with antimicrobial residues), the use of shared fomites in the barn, ventilation/air quality-related parameters, the frequency of travel, the number of horses stabled at the barns, and previous hospitalizations. Barn activity was also studied as a risk factor on the basis of previous work suggesting that racehorses are at increased risk of nasal MRS colonization compared with broodmares and riding horses [6]. It is hard to believe, however, that racing per se could be a risk factor for that. Rather, it is plausible that management practices or physical features of racehorses represent real risk factors for the reported increase in MRS prevalence. Race activity was associated with a younger age, frequent habit of sharing tacks, increased travel frequency, and increased frequency of antimicrobial treatments in our study. This latter point is also likely linked to the young age of the horses [41], and available data suggest that antimicrobials may be overused in racehorses [42]. In line with this, our model for predictors of equine MRS colonization had a high mean VIF when barn activity was included (collinearity), and removal of this variable resulted in an overall improvement in the VIF to values close to 1. The final analysis revealed barn-estimated antimicrobial treatments as the only significant risk factor for MRS carriage in horses, significantly interacting with the habit of sharing tacks, whereas good and optimal ventilation indexes appeared to be a significant protective factor in this regard. These findings confirm that antimicrobial administration represents a crucial determinant of antimicrobial resistance in commensal bacteria. The same findings also highlight the detrimental impact of indirect exposure to antimicrobial treatments.

The significant protective effect of variable ventilation on equine MRS colonization deserves attention. Staphylococcus spp. are recognized as microorganisms capable of airborne dissemination and transmission, even if the precise dynamics of airborne infection remain elusive [43]. The airborne spread of antimicrobial resistance genes and bacteria of animal origin into the environment and the colonization of humans who share the same environment have been recently described [44–46]. From this perspective, the so-called “open air factor”, wherein properties of outdoor air can reduce the viability and virulence of airborne microorganisms [40], might have played a role by decreasing humidity or increasing sunlight exposure of the environment in which the horses lived during our study. Our data suggest that, even for horses kept inside the barn for most of the day, good air quality (resulting from barn and box air exchange, overall air quality) may significantly contrast the ability of MRS to spread. The statistical significance of the test for the trend for the variable ventilation further suggests that at increasing levels of perceived air quality, there is a greater effect in terms of MRS carriage prevalence reduction. This also offers a rough validation of our air quality assessment method. The lack of a significant association between MRS carriage and variables concerning air quality other than the number of windows in the box where horses were housed at the initial regression analysis was likely due to the low power of the study. Although our work was not designed to study in detail the effects of the environment on bacterial loads or survival, our results support the paramount importance of adequate barn ventilation and turnout time in the management and wellbeing of horses and, indirectly, for people working with them.

For human MRS colonization, the risk factors studied were mainly related to horse management practices, the health conditions of the people studied, and hand hygiene. Our data support the fact that uncontrolled management practices in horses, especially concerning antimicrobial treatments, may act as an indirect risk factor for increased MRS colonization in caregivers and that the risk is increased under specific conditions, such as in racehorse barns. To the authors’ knowledge, there are currently no reports of the horizontal transfer of MR-CoNS between horses and humans. The increased prevalence of equine MRS isolates at the barn level associated with MRS colonization in personnel has also been reported for MRSA [3], suggesting that different Staphylococcus spp. may behave similarly concerning the mechanisms of acquisition of antimicrobial resistance genes. This, combined with the high prevalence of methicillin-sensitive S. aureus physiologically colonizing equine [47] and human nostrils and skin [48], should warn against the ease with which resistance genes could be transferred from CoNS to S. aureus or other coagulase-positive Staphylococci [49, 50], with important health implications.

The most common isolates from horses were S. sciuri and S. fleurettii. They were all MRCoNS. S. sciuri is commonly reported as a nose commensal in horses [15, 17, 19]. S. fleurettii was first isolated and described in 2000 from goat milk cheeses [20], and it is recognized as a component of the commensal flora of goats, pigs and small mammals [2]. S. fleurettii is intrinsically resistant to novobiocin [20]. The available literature suggests that S. fleurettii is a rare commensal of the horse nasal flora that is generally susceptible to methicillin [19]. This study is the first to report methicillin-resistant S. fleurettii colonization in horses, which was identified in 9 horses from 6 barns, and 7 out of 9 isolates were MDRS. All the isolates expressed the mecA gene, except for S. cohnii, S. saprophyticus, and 2 of the 17 S. sciuri isolates, which, however, presented phenotypic resistance to cefoxitine, penicillin, and/or ceftiofur. This may be because several homologues exist for the mecA gene, especially in MRCoNS [2], including those described in S. sciuri (mecA1) and S. saprophyticus (mecC2), with 79 and 92% identity with mecA, respectively. While previous evidence suggests that MRCoNS may play a role in the emergence of MRSA as a potential source and reservoir of the mecA gene, recent evidence challenges this unidirectional view, suggesting that it can also act as a protective factor against massive MRSA colonization in certain subsets of patients.

The data presented here were collected in 2019 after several warnings of antimicrobial disuse in animal species. At that time, regulations on antimicrobial residues in feeds (DGSAF 0021392-P-11/05/2015) only regarded animals intended for food consumption and were fixed at the maximal threshold of 1 mg/kg for all molecules except for penicillins, for which the limit was 0.5 mg/kg. Since then, however, research on this topic has shown that levels as low as 2 µg/kg trimethoprim can drive AMR in commensal bacteria from exposed horses, while insufficient data have prevented the drawing of relevant conclusions for β-lactams [51, 52]. These concentrations are very close to, and in some cases even lower than, the lower LOD of the available instruments. As most horses used for sports activities are not intended for food consumption, there are actually no regulations or controls on their feeds. In the context of the feed industry, medicated and nonmedicated feeds produced for different animal species can be produced from the same plants, using the same production line, following cleaning operations, which may be partly ineffective and result in unintended antimicrobial residue carry-over in feeds [53]. Given the relevance of horses as potential sources of AMR bacteria that can colonize humans, surveillance on this side may provide new meaningful information on AMR-driving mechanisms. Additionally, to further dissect the roles that several factors are likely to play in AMR development in the equine bacterial community, it must be acknowledged that, in 2019, Italy introduced a compulsory veterinary electronic prescription system. With this system, antimicrobial prescription was strictly regulated and controlled, resulting in a significant drop in annual prescription sales, as reported by the most recent ESVAC report [54].

In conclusion, our data confirm and expand previous findings in support of antimicrobial treatment exposure, either directly or indirectly, as the main determinant of MRS colonization in horses. Our findings highlight barn-level antimicrobial exposure as a risk factor for MRS colonization within an equine population, as well as evidence that good barn ventilation is a protective factor in this regard. In our study, caregivers of racehorses had an increased prevalence of MRS colonization compared with caregivers of show or pleasure horses. Whether this is associated with negative health outcomes in this occupational niche remains undetermined. Finally, barn-level horse-administered antimicrobial treatment was a significant risk factor for human MRS colonization. These findings emphasize the importance of antimicrobial resistance surveillance programs based on One Health approaches in workplaces where human‒animal contact occurs on a regular basis.

Supplementary Information

Additional file 1. Supplementary methods and results.

Additional file 2. Questionnaires used for collecting barn, horse, and personnel data.

Additional file 3. List of antimicrobial molecules tested for residues in feed.

Acknowledgements

This work was carried out within the framework of the postgraduate master’s course in epidemiology of the University of Turin. The authors would like to thank Prof. Annibale Biggeri for tutoring during the Master Course.

Authors' contributions

Study conception and design of the work: MB, AT; data acquisition: MB, AB, PR, PN, DM, SM; data analysis: MB, GR; data interpretation: MB, AB, GR; manuscript draft and substantial review: MB, AT, GR. All authors read and approved the final manuscript.

Funding

This study was supported by Fondazione CRT, Erogazioni Ordinarie (RF #2018.0587).

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author upon reasonable request.

Declarations

Ethics approval and consent to participate

The procedures described in this study were approved by the Animal Ethical and Welfare Committee of the Department of Veterinary Medicine (Prot. N. 936, 16/04/2019), University of Turin, and by the Ethical Committee of the Azienda Ospedaliera Universitaria San Luigi Gonzaga (Prot. 63/2019). Written informed consent was obtained from the horse owners and the recruited personnel.

Competing interests

The authors declare that they have no competing interests.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Hogan PG Mork RL Boyle MG Muenks CE Morelli JJ Thompson RM Sullivan ML Gehlert SJ Merlo JR McKenzie MG Wardenburg JB Rzhetsky A Burnham CD Fritz SA Interplay of personal, pet, and environmental colonization in households affected by community-associated methicillin-resistant Staphylococcus aureus J Infect 2019 78 200 207 10.1016/j.jinf.2018.11.006 30503843
Hogan PG, Mork RL, Boyle MG, Muenks CE, Morelli JJ, Thompson RM, Sullivan ML, Gehlert SJ, Merlo JR, McKenzie MG, Wardenburg JB, Rzhetsky A, Burnham CD, Fritz SA (2019) Interplay of personal, pet, and environmental colonization in households affected by community-associated methicillin-resistant Staphylococcus aureus. J Infect 78:200–20730503843 10.1016/j.jinf.2018.11.006
2. Zainab SM Junaid M Xu N Malik RN Antibiotics and antibiotic resistant genes (ARGs) in groundwater: a global review on dissemination, sources, interactions, environmental and human health risks Water Res 2020 187 116455 10.1016/j.watres.2020.116455 33032106
Zainab SM, Junaid M, Xu N, Malik RN (2020) Antibiotics and antibiotic resistant genes (ARGs) in groundwater: a global review on dissemination, sources, interactions, environmental and human health risks. Water Res 187:11645533032106 10.1016/j.watres.2020.116455
3. Grundmann H Aires-de-Sousa M Boyce J Tiemersma E Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat Lancet 2006 368 874 885 10.1016/S0140-6736(06)68853-3 16950365
Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E (2006) Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368:874–88516950365 10.1016/S0140-6736(06)68853-3
4. Bollig ER Granick JL Webb TL Ward C Beaudoin AL A quarterly survey of antibiotic prescribing in small animal and equine practices-Minnesota and North Dakota, 2020 Zoonoses Public Health 2022 69 864 874 10.1111/zph.12979 35643964
Bollig ER, Granick JL, Webb TL, Ward C, Beaudoin AL (2022) A quarterly survey of antibiotic prescribing in small animal and equine practices-Minnesota and North Dakota, 2020. Zoonoses Public Health 69:864–87435643964 10.1111/zph.12979
5. Fitzgerald JR Livestock-associated Staphylococcus aureus: origin, evolution and public health threat Trends Microbiol 2012 20 192 198 10.1016/j.tim.2012.01.006 22386364
Fitzgerald JR (2012) Livestock-associated Staphylococcus aureus: origin, evolution and public health threat. Trends Microbiol 20:192–19822386364 10.1016/j.tim.2012.01.006
6. Mehta A Rodrigues C Kumar R Rattan A Sridhar H Mattoo V Ginde V A pilot programme of MRSA surveillance in India. (MRSA Surveillance Study Group) J Postgrad Med 1996 42 1 3 9715287
Mehta A, Rodrigues C, Kumar R, Rattan A, Sridhar H, Mattoo V, Ginde V (1996) A pilot programme of MRSA surveillance in India. (MRSA Surveillance Study Group). J Postgrad Med 42:1–39715287
7. Van Embden JD Van Soolingen D Heersma HF De Neeling AJ Jones ME Steiert M Grek V Mooi FR Verhoef J Establishment of a European network for the surveillance of Mycobacterium tuberculosis, MRSA and penicillin-resistant pneumococci J Antimicrob Chemother 1996 38 905 907 10.1093/jac/38.5.905 8961063
Van Embden JD, Van Soolingen D, Heersma HF, De Neeling AJ, Jones ME, Steiert M, Grek V, Mooi FR, Verhoef J (1996) Establishment of a European network for the surveillance of Mycobacterium tuberculosis, MRSA and penicillin-resistant pneumococci. J Antimicrob Chemother 38:905–9078961063 10.1093/jac/38.5.905
8. Johnson AP Davies J Guy R Abernethy J Sheridan E Pearson A Duckworth G Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years J Antimicrob Chemother 2012 67 802 809 10.1093/jac/dkr561 22223229
Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, Duckworth G (2012) Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 67:802–80922223229 10.1093/jac/dkr561
9. Schonfeld V Diercke M Gilsdorf A Eckmanns T Walter J Evaluation of the statutory surveillance system for invasive MRSA infections in Germany, 2016–2017 BMC Public Health 2018 18 1063 10.1186/s12889-018-5971-y 30143016
Schonfeld V, Diercke M, Gilsdorf A, Eckmanns T, Walter J (2018) Evaluation of the statutory surveillance system for invasive MRSA infections in Germany, 2016–2017. BMC Public Health 18:106330143016 10.1186/s12889-018-5971-y
10. Jordan D Simon J Fury S Moss S Giffard P Maiwald M Southwell P Barton MD Axon JE Morris SG Trott DJ Carriage of methicillin-resistant Staphylococcus aureus by veterinarians in Australia Aust Vet J 2011 89 152 159 10.1111/j.1751-0813.2011.00710.x 21495985
Jordan D, Simon J, Fury S, Moss S, Giffard P, Maiwald M, Southwell P, Barton MD, Axon JE, Morris SG, Trott DJ (2011) Carriage of methicillin-resistant Staphylococcus aureus by veterinarians in Australia. Aust Vet J 89:152–15921495985 10.1111/j.1751-0813.2011.00710.x
11. Becker K Both A Weisselberg S Heilmann C Rohde H Emergence of coagulase-negative staphylococci Expert Rev Anti Infect Ther 2020 18 349 366 10.1080/14787210.2020.1730813 32056452
Becker K, Both A, Weisselberg S, Heilmann C, Rohde H (2020) Emergence of coagulase-negative staphylococci. Expert Rev Anti Infect Ther 18:349–36632056452 10.1080/14787210.2020.1730813
12. Becker K Heilmann C Peters G Coagulase-negative staphylococci Clin Microbiol Rev 2014 27 870 926 10.1128/CMR.00109-13 25278577
Becker K, Heilmann C, Peters G (2014) Coagulase-negative staphylococci. Clin Microbiol Rev 27:870–92625278577 10.1128/CMR.00109-13
13. Catry B Van Duijkeren E Pomba MC Greko C Moreno MA Pyörälä S Ruzauskas M Sanders P Threlfall EJ Ungemach F Törneke K Munoz-Madero C Torren-Edo J Reflection paper on MRSA in food-producing and companion animals: epidemiology and control options for human and animal health Epidemiol Infect 2010 138 626 644 10.1017/S0950268810000014 20141646
Catry B, Van Duijkeren E, Pomba MC, Greko C, Moreno MA, Pyörälä S, Ruzauskas M, Sanders P, Threlfall EJ, Ungemach F, Törneke K, Munoz-Madero C, Torren-Edo J (2010) Reflection paper on MRSA in food-producing and companion animals: epidemiology and control options for human and animal health. Epidemiol Infect 138:626–64420141646 10.1017/S0950268810000014
14. Loeffler A Pfeiffer DU Lindsay JA Soares Magalhaes RJ Lloyd DH Prevalence of and risk factors for MRSA carriage in companion animals: a survey of dogs, cats and horses Epidemiol Infect 2011 139 1019 1028 10.1017/S095026881000227X 20943000
Loeffler A, Pfeiffer DU, Lindsay JA, Soares Magalhaes RJ, Lloyd DH (2011) Prevalence of and risk factors for MRSA carriage in companion animals: a survey of dogs, cats and horses. Epidemiol Infect 139:1019–102820943000 10.1017/S095026881000227X
15. Weese JS Lefebvre SL Risk factors for methicillin-resistant Staphylococcus aureus colonization in horses admitted to a veterinary teaching hospital Can Vet J 2007 48 921 926 17966332
Weese JS, Lefebvre SL (2007) Risk factors for methicillin-resistant Staphylococcus aureus colonization in horses admitted to a veterinary teaching hospital. Can Vet J 48:921–92617966332
16. Weese JS Rousseau J Traub-Dargatz JL Willey BM McGeer AJ Low DE Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses J Am Vet Med Assoc 2005 226 580 583 10.2460/javma.2005.226.580 15742700
Weese JS, Rousseau J, Traub-Dargatz JL, Willey BM, McGeer AJ, Low DE (2005) Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses. J Am Vet Med Assoc 226:580–58315742700 10.2460/javma.2005.226.580
17. Adams R Smith J Locke S Phillips E Erol E Carter C Odoi A An epidemiologic study of antimicrobial resistance of Staphylococcus species isolated from equine samples submitted to a diagnostic laboratory BMC Vet Res 2018 14 42 10.1186/s12917-018-1367-6 29402294
Adams R, Smith J, Locke S, Phillips E, Erol E, Carter C, Odoi A (2018) An epidemiologic study of antimicrobial resistance of Staphylococcus species isolated from equine samples submitted to a diagnostic laboratory. BMC Vet Res 14:4229402294 10.1186/s12917-018-1367-6
18. EFSA Panel on Animal Health and Welfare (AHAW)Nielsen SS Bicout DJ Calistri P Canali E Drewe JA Garin-Bastuji B Gonzales Rojas JL Gortazar Schmidt C Herskin M Michel V Miranda Chueca MA Padalino B Pasquali P Roberts HC Sihvonen LH Spoolder H Stahl K Velarde A Viltrop A Winckler C Dewulf J Guardabassi L Hilbert F Mader R Baldinelli F Alvarez J Assessment of animal diseases caused by bacteria resistant to antimicrobials: horses EFSA J 2021 19 e07112 34987627
EFSA Panel on Animal Health and Welfare (AHAW), Nielsen SS, Bicout DJ, Calistri P, Canali E, Drewe JA, Garin-Bastuji B, Gonzales Rojas JL, Gortazar Schmidt C, Herskin M, Michel V, Miranda Chueca MA, Padalino B, Pasquali P, Roberts HC, Sihvonen LH, Spoolder H, Stahl K, Velarde A, Viltrop A, Winckler C, Dewulf J, Guardabassi L, Hilbert F, Mader R, Baldinelli F, Alvarez J (2021) Assessment of animal diseases caused by bacteria resistant to antimicrobials: horses. EFSA J 19:e0711234987627
19. Roudaud M Allano M Fairbrother JH Sauve F A retrospective study on methicillin-resistant Staphylococcus spp. isolated from horses admitted to a Canadian veterinary teaching hospital between 2008 and 2018 Can Vet J 2020 61 1197 1202 33149358
Roudaud M, Allano M, Fairbrother JH, Sauve F (2020) A retrospective study on methicillin-resistant Staphylococcus spp. isolated from horses admitted to a Canadian veterinary teaching hospital between 2008 and 2018. Can Vet J 61:1197–120233149358
20. Tirosh-Levy S Steinman A Carmeli Y Klement E Navon-Venezia S Prevalence and risk factors for colonization with methicillin resistant Staphylococcus aureus and other Staphylococci species in hospitalized and farm horses in Israel Prev Vet Med 2015 122 135 144 10.1016/j.prevetmed.2015.09.007 26417658
Tirosh-Levy S, Steinman A, Carmeli Y, Klement E, Navon-Venezia S (2015) Prevalence and risk factors for colonization with methicillin resistant Staphylococcus aureus and other Staphylococci species in hospitalized and farm horses in Israel. Prev Vet Med 122:135–14426417658 10.1016/j.prevetmed.2015.09.007
21. Mallardo K Nizza S Fiorito F Pagnini U De Martino L A comparative evaluation of methicillin-resistant staphylococci isolated from harness racing-horses, breeding mares and riding-horses in Italy Asian Pac J Trop Biomed 2013 3 169 173 10.1016/S2221-1691(13)60044-1 23620832
Mallardo K, Nizza S, Fiorito F, Pagnini U, De Martino L (2013) A comparative evaluation of methicillin-resistant staphylococci isolated from harness racing-horses, breeding mares and riding-horses in Italy. Asian Pac J Trop Biomed 3:169–17323620832 10.1016/S2221-1691(13)60044-1
22. Peterson AE Davis MF Awantang G Limbago B Fosheim GE Silbergeld EK Correlation between animal nasal carriage and environmental methicillin-resistant Staphylococcus aureus isolates at U.S. horse and cattle farms Vet Microbiol 2012 160 539 543 10.1016/j.vetmic.2012.06.032 22795260
Peterson AE, Davis MF, Awantang G, Limbago B, Fosheim GE, Silbergeld EK (2012) Correlation between animal nasal carriage and environmental methicillin-resistant Staphylococcus aureus isolates at U.S. horse and cattle farms. Vet Microbiol 160:539–54322795260 10.1016/j.vetmic.2012.06.032
23. Van den Eede A Martens A Feryn I Vanderhaeghen W Lipinska U Gasthuys F Butaye P Haesebrouck F Hermans K Low MRSA prevalence in horses at farm level BMC Vet Res 2012 8 213 10.1186/1746-6148-8-213 23134703
Van den Eede A, Martens A, Feryn I, Vanderhaeghen W, Lipinska U, Gasthuys F, Butaye P, Haesebrouck F, Hermans K (2012) Low MRSA prevalence in horses at farm level. BMC Vet Res 8:21323134703 10.1186/1746-6148-8-213
24. Groves MD Crouch B Coombs GW Jordan D Pang S Barton MD Giffard P Abraham S Trott DJ Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from Australian veterinarians PLoS ONE 2016 11 e0146034 10.1371/journal.pone.0146034 26735694
Groves MD, Crouch B, Coombs GW, Jordan D, Pang S, Barton MD, Giffard P, Abraham S, Trott DJ (2016) Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from Australian veterinarians. PLoS One 11:e014603426735694 10.1371/journal.pone.0146034
25. Moodley A Nightingale EC Stegger M Nielsen SS Skov RL Guardabassi L High risk for nasal carriage of methicillin-resistant Staphylococcus aureus among Danish veterinary practitioners Scand J Work Environ Health 2008 34 151 157 10.5271/sjweh.1219 18470441
Moodley A, Nightingale EC, Stegger M, Nielsen SS, Skov RL, Guardabassi L (2008) High risk for nasal carriage of methicillin-resistant Staphylococcus aureus among Danish veterinary practitioners. Scand J Work Environ Health 34:151–15718470441 10.5271/sjweh.1219
26. Maddox TW Pinchbeck GL Clegg PD Wedley AL Dawson S Williams NJ Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 2: risk factors for faecal carriage of antimicrobial-resistant Escherichia coli in horses Equine Vet J 2012 44 297 303 10.1111/j.2042-3306.2011.00440.x 21848536
Maddox TW, Pinchbeck GL, Clegg PD, Wedley AL, Dawson S, Williams NJ (2012) Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 2: risk factors for faecal carriage of antimicrobial-resistant Escherichia coli in horses. Equine Vet J 44:297–30321848536 10.1111/j.2042-3306.2011.00440.x
27. Van den Eede A Hermans K Van den Abeele A Flore K Dewulf J Vanderhaeghen W Némeghaire S Butaye P Gasthuys F Haesebrouck F Martens A The nasal vestibulum is the optimal sampling site for MRSA screening in hospitalised horses Vet J 2013 197 415 419 10.1016/j.tvjl.2013.01.031 23465751
Van den Eede A, Hermans K, Van den Abeele A, Flore K, Dewulf J, Vanderhaeghen W, Némeghaire S, Butaye P, Gasthuys F, Haesebrouck F, Martens A (2013) The nasal vestibulum is the optimal sampling site for MRSA screening in hospitalised horses. Vet J 197:415–41923465751 10.1016/j.tvjl.2013.01.031
28. Bocher S Smyth R Kahlmeter G Kerremans J Vos MC Skov R Evaluation of four selective agars and two enrichment broths in screening for methicillin-resistant Staphylococcus aureus J Clin Microbiol 2008 46 3136 3138 10.1128/JCM.00478-08 18632905
Bocher S, Smyth R, Kahlmeter G, Kerremans J, Vos MC, Skov R (2008) Evaluation of four selective agars and two enrichment broths in screening for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 46:3136–313818632905 10.1128/JCM.00478-08
29. Smyth RW Kahlmeter G Mannitol salt agar-cefoxitin combination as a screening medium for methicillin-resistant Staphylococcus aureus J Clin Microbiol 2005 43 3797 3799 10.1128/JCM.43.8.3797-3799.2005 16081913
Smyth RW, Kahlmeter G (2005) Mannitol salt agar-cefoxitin combination as a screening medium for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43:3797–379916081913 10.1128/JCM.43.8.3797-3799.2005
30. Stegger M Andersen PS Kearns A Pichon B Holmes MA Edwards G Laurent F Teale C Skov R Larsen AR Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecA(LGA251) Clin Microbiol Infect 2012 18 395 400 10.1111/j.1469-0691.2011.03715.x 22429460
Stegger M, Andersen PS, Kearns A, Pichon B, Holmes MA, Edwards G, Laurent F, Teale C, Skov R, Larsen AR (2012) Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecA(LGA251). Clin Microbiol Infect 18:395–40022429460 10.1111/j.1469-0691.2011.03715.x
31. Johnston R Jones K Manley D Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British voting behaviour Qual Quant 2018 52 1957 1976 10.1007/s11135-017-0584-6 29937587
Johnston R, Jones K, Manley D (2018) Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British voting behaviour. Qual Quant 52:1957–197629937587 10.1007/s11135-017-0584-6
32. Boyle AG Timoney JF Newton JR Hines MT Waller AS Buchanan BR Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles-revised consensus statement J Vet Intern Med 2018 32 633 647 10.1111/jvim.15043 29424487
Boyle AG, Timoney JF, Newton JR, Hines MT, Waller AS, Buchanan BR (2018) Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles-revised consensus statement. J Vet Intern Med 32:633–64729424487 10.1111/jvim.15043
33. Dayaram A Seeber PA Greenwood AD Environmental detection and potential transmission of equine herpesviruses Pathogens 2021 10 423 10.3390/pathogens10040423 33916280
Dayaram A, Seeber PA, Greenwood AD (2021) Environmental detection and potential transmission of equine herpesviruses. Pathogens 10:42333916280 10.3390/pathogens10040423
34. Busscher JF van Duijkeren E van Sloet MM The prevalence of methicillin-resistant staphylococci in healthy horses in the Netherlands Vet Microbiol 2006 113 131 136 10.1016/j.vetmic.2005.10.028 16303264
Busscher JF, van Duijkeren E, van Sloet MM (2006) The prevalence of methicillin-resistant staphylococci in healthy horses in the Netherlands. Vet Microbiol 113:131–13616303264 10.1016/j.vetmic.2005.10.028
35. Maddox TW Clegg PD Diggle PJ Wedley AL Dawson S Pinchbeck GL Williams NJ Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 1: prevalence of antimicrobial-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus Equine Vet J 2012 44 289 296 10.1111/j.2042-3306.2011.00441.x 21848534
Maddox TW, Clegg PD, Diggle PJ, Wedley AL, Dawson S, Pinchbeck GL, Williams NJ (2012) Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 1: prevalence of antimicrobial-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus. Equine Vet J 44:289–29621848534 10.1111/j.2042-3306.2011.00441.x
36. Bortolami A Williams NJ McGowan CM Kelly PG Archer DC Corro M Pinchbeck G Saunders CJ Timofte D Environmental surveillance identifies multiple introductions of MRSA CC398 in an Equine Veterinary Hospital in the UK, 2011–2016 Sci Rep 2017 7 5499 10.1038/s41598-017-05559-8 28710350
Bortolami A, Williams NJ, McGowan CM, Kelly PG, Archer DC, Corro M, Pinchbeck G, Saunders CJ, Timofte D (2017) Environmental surveillance identifies multiple introductions of MRSA CC398 in an Equine Veterinary Hospital in the UK, 2011–2016. Sci Rep 7:549928710350 10.1038/s41598-017-05559-8
37. Carfora V Caprioli A Grossi I Pepe M Alba P Lorenzetti S Amoruso R Sorbara L Franco A Battisti A A methicillin-resistant Staphylococcus aureus (MRSA) sequence type 8, spa type t11469 causing infection and colonizing horses in Italy Pathog Dis 2016 74 ftw025 10.1093/femspd/ftw025 27052029
Carfora V, Caprioli A, Grossi I, Pepe M, Alba P, Lorenzetti S, Amoruso R, Sorbara L, Franco A, Battisti A (2016) A methicillin-resistant Staphylococcus aureus (MRSA) sequence type 8, spa type t11469 causing infection and colonizing horses in Italy. Pathog Dis 74:ftw02527052029 10.1093/femspd/ftw025
38. Cuny C Abdelbary MMH Kock R Layer F Scheidemann W Werner G Witte W Methicillin-resistant Staphylococcus aureus from infections in horses in Germany are frequent colonizers of veterinarians but rare among MRSA from infections in humans One Health 2015 2 11 17 10.1016/j.onehlt.2015.11.004 28616471
Cuny C, Abdelbary MMH, Kock R, Layer F, Scheidemann W, Werner G, Witte W (2015) Methicillin-resistant Staphylococcus aureus from infections in horses in Germany are frequent colonizers of veterinarians but rare among MRSA from infections in humans. One Health 2:11–1728616471 10.1016/j.onehlt.2015.11.004
39. Van den Eede A Martens A Flore K Denis O Gasthuys F Haesebrouck F Van den Abeele A Hermans K MRSA carriage in the equine community: an investigation of horse-caretaker couples Vet Microbiol 2013 163 313 318 10.1016/j.vetmic.2012.12.038 23434186
Van den Eede A, Martens A, Flore K, Denis O, Gasthuys F, Haesebrouck F, Van den Abeele A, Hermans K (2013) MRSA carriage in the equine community: an investigation of horse-caretaker couples. Vet Microbiol 163:313–31823434186 10.1016/j.vetmic.2012.12.038
40. Loncaric I Tichy A Handler S Szostak MP Tickert M Diab-Elschahawi M Spergser J Künzel F Prevalence of methicillin-resistant Staphylococcus sp. (MRS) in different companion animals and determination of risk factors for colonization with MRS Antibiotics 2019 8 36 10.3390/antibiotics8020036 30959767
Loncaric I, Tichy A, Handler S, Szostak MP, Tickert M, Diab-Elschahawi M, Spergser J, Künzel F (2019) Prevalence of methicillin-resistant Staphylococcus sp. (MRS) in different companion animals and determination of risk factors for colonization with MRS. Antibiotics 8:3630959767 10.3390/antibiotics8020036
41. Rossi TM Moore A O’Sullivan TL Greer AL Equine rhinitis a virus infection at a standardbred training facility: incidence, clinical signs, and risk factors for clinical disease Front Vet Sci 2019 6 71 10.3389/fvets.2019.00071 30918893
Rossi TM, Moore A, O’Sullivan TL, Greer AL (2019) Equine rhinitis a virus infection at a standardbred training facility: incidence, clinical signs, and risk factors for clinical disease. Front Vet Sci 6:7130918893 10.3389/fvets.2019.00071
42. Weese JS Sabino C Scrutiny of antimicrobial use in racing horses with allergic small airway inflammatory disease Can Vet J 2005 46 438 489 16018565
Weese JS, Sabino C (2005) Scrutiny of antimicrobial use in racing horses with allergic small airway inflammatory disease. Can Vet J 46:438–48916018565
43. Hobday RA Dancer SJ Roles of sunlight and natural ventilation for controlling infection: historical and current perspectives J Hosp Infect 2013 84 271 282 10.1016/j.jhin.2013.04.011 23790506
Hobday RA, Dancer SJ (2013) Roles of sunlight and natural ventilation for controlling infection: historical and current perspectives. J Hosp Infect 84:271–28223790506 10.1016/j.jhin.2013.04.011
44. Angen O Nielsen MW Lofstrom P Larsen AR Hendriksen NB Airborne spread of methicillin resistant Staphylococcus aureus from a swine farm Front Vet Sci 2021 8 644729 10.3389/fvets.2021.644729 34150881
Angen O, Nielsen MW, Lofstrom P, Larsen AR, Hendriksen NB (2021) Airborne spread of methicillin resistant Staphylococcus aureus from a swine farm. Front Vet Sci 8:64472934150881 10.3389/fvets.2021.644729
45. Bai H He LY Wu DL Gao FZ Zhang M Zou HY Yao MS Ying GG Spread of airborne antibiotic resistance from animal farms to the environment: dispersal pattern and exposure risk Environ Int 2021 158 106927 10.1016/j.envint.2021.106927 34673316
Bai H, He LY, Wu DL, Gao FZ, Zhang M, Zou HY, Yao MS, Ying GG (2021) Spread of airborne antibiotic resistance from animal farms to the environment: dispersal pattern and exposure risk. Environ Int 158:10692734673316 10.1016/j.envint.2021.106927
46. Bos ME Verstappen KM van Cleef BA Dohmen W Dorado-Garcia A Graveland H Duim B Wagenaar JA Kluytmans JA Heederik DJ Transmission through air as a possible route of exposure for MRSA J Expo Sci Environ Epidemiol 2016 26 263 269 10.1038/jes.2014.85 25515375
Bos ME, Verstappen KM, van Cleef BA, Dohmen W, Dorado-Garcia A, Graveland H, Duim B, Wagenaar JA, Kluytmans JA, Heederik DJ (2016) Transmission through air as a possible route of exposure for MRSA. J Expo Sci Environ Epidemiol 26:263–26925515375 10.1038/jes.2014.85
47. Kaiser-Thom S Gerber V Collaud A Hurni J Perreten V Prevalence and WGS-based characteristics of Staphylococcus aureus in the nasal mucosa and pastern of horses with equine pastern dermatitis BMC Vet Res 2022 18 79 10.1186/s12917-021-03053-y 35209904
Kaiser-Thom S, Gerber V, Collaud A, Hurni J, Perreten V (2022) Prevalence and WGS-based characteristics of Staphylococcus aureus in the nasal mucosa and pastern of horses with equine pastern dermatitis. BMC Vet Res 18:7935209904 10.1186/s12917-021-03053-y
48. Congdon ST Guaglione JA Ricketts OMA Murphy KV Anderson MG Trowbridge DA Al-Abduladheem Y Phillips AM Beausoleil AM Stanley AJ Becker TJ Silver AC Prevalence and antibiotic resistance of Staphylococcus aureus associated with a college-aged cohort: life-style factors that contribute to nasal carriage Front Cell Infect Microbiol 2023 13 1195758 10.3389/fcimb.2023.1195758 37441241
Congdon ST, Guaglione JA, Ricketts OMA, Murphy KV, Anderson MG, Trowbridge DA, Al-Abduladheem Y, Phillips AM, Beausoleil AM, Stanley AJ, Becker TJ, Silver AC (2023) Prevalence and antibiotic resistance of Staphylococcus aureus associated with a college-aged cohort: life-style factors that contribute to nasal carriage. Front Cell Infect Microbiol 13:119575837441241 10.3389/fcimb.2023.1195758
49. Liu G Thomsen LE Olsen JE Antimicrobial-induced horizontal transfer of antimicrobial resistance genes in bacteria: a mini-review J Antimicrob Chemother 2022 77 556 567 10.1093/jac/dkab450 34894259
Liu G, Thomsen LE, Olsen JE (2022) Antimicrobial-induced horizontal transfer of antimicrobial resistance genes in bacteria: a mini-review. J Antimicrob Chemother 77:556–56734894259 10.1093/jac/dkab450
50. Martins A Cunha Mde L Methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci: epidemiological and molecular aspects Microbiol Immunol 2007 51 787 795 10.1111/j.1348-0421.2007.tb03968.x 17895595
Martins A, Cunha Mde L (2007) Methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci: epidemiological and molecular aspects. Microbiol Immunol 51:787–79517895595 10.1111/j.1348-0421.2007.tb03968.x
51. EFSA Panel on Biological Hazards (BIOHAZ)Koutsoumanis K Allende A Alvarez-Ordóñez A Bolton D Bover-Cid S Chemaly M Davies R De Cesare A Herman L Hilbert F Lindqvist R Nauta M Ru G Simmons M Skandamis P Suffredini E Andersson DI Bampidis V Bengtsson-Palme J Bouchard D Ferran A Kouba M López Puente S López-Alonso M Nielsen SS Pechová A Petkova M Girault S Broglia A Guerra B Innocenti ML Liébana E López-Gálvez G Manini P Stella P Peixe L Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed Part 13: Diaminopyrimidines: trimethoprim EFSA J 2021 19 e06865 34729093
EFSA Panel on Biological Hazards (BIOHAZ), Koutsoumanis K, Allende A, Alvarez-Ordóñez A, Bolton D, Bover-Cid S, Chemaly M, Davies R, De Cesare A, Herman L, Hilbert F, Lindqvist R, Nauta M, Ru G, Simmons M, Skandamis P, Suffredini E, Andersson DI, Bampidis V, Bengtsson-Palme J, Bouchard D, Ferran A, Kouba M, López Puente S, López-Alonso M, Nielsen SS, Pechová A, Petkova M, Girault S, Broglia A, Guerra B, Innocenti ML, Liébana E, López-Gálvez G, Manini P, Stella P, Peixe L (2021) Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed Part 13: Diaminopyrimidines: trimethoprim. EFSA J 19:e0686534729093
52. EFSA Panel on Biological Hazards (BIOHAZ)Koutsoumanis K Allende A Alvarez-Ordóñez A Bolton D Bover-Cid S Chemaly M Davies R De Cesare A Herman L Hilbert F Lindqvist R Nauta M Ru G Simmons M Skandamis P Suffredini E Andersson DI Bampidis V Bengtsson-Palme J Bouchard D Ferran A Kouba M López Puente S López-Alonso M Nielsen SS Pechová A Petkova M Girault S Broglia A Guerra B Innocenti ML Liébana E López-Gálvez G Manini P Stella P Peixe L Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 4: beta-lactams: Amoxicillin and penicillin V EFSA J 2021 19 e06855 34729084
EFSA Panel on Biological Hazards (BIOHAZ), Koutsoumanis K, Allende A, Alvarez-Ordóñez A, Bolton D, Bover-Cid S, Chemaly M, Davies R, De Cesare A, Herman L, Hilbert F, Lindqvist R, Nauta M, Ru G, Simmons M, Skandamis P, Suffredini E, Andersson DI, Bampidis V, Bengtsson-Palme J, Bouchard D, Ferran A, Kouba M, López Puente S, López-Alonso M, Nielsen SS, Pechová A, Petkova M, Girault S, Broglia A, Guerra B, Innocenti ML, Liébana E, López-Gálvez G, Manini P, Stella P, Peixe L (2021) Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 4: beta-lactams: Amoxicillin and penicillin V. EFSA J 19:e0685534729084
53. Avolio R Pederiva S Morello S Crescio MI Ru G Grifoni F Abete MC Marchis D Official controls on carry-over of antibiotics in feed: a useful tool to contain the development of antibiotic resistance Anim Husb Dairy Vet Sci 2021 5 1 3 10.15761/AHDVS.1000185
Avolio R, Pederiva S, Morello S, Crescio MI, Ru G, Grifoni F, Abete MC, Marchis D (2021) Official controls on carry-over of antibiotics in feed: a useful tool to contain the development of antibiotic resistance. Anim Husb Dairy Vet Sci 5:1–310.15761/AHDVS.1000185
54. European Medicines Agency ESoVAC (2022) Sales of veterinary antimicrobial agents in 31 European countries in 2022. (EMA/299538/2023) https://www.ema.europa.eu/en/documents/report/sales-veterinary-antimicrobial-agents-31-european-countries-2022-trends-2010-2022-thirteenth-esvac-report_en.pdf. Accessed 18 July 2024
